Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Biocom & DPAc Roundtable Lunch

When:

Tue May 02 18:30:00 GMT 2017 - Tue May 02 19:30:00 GMT 2017

Where:

Haworth Los Angeles Showroom
444 S. Flower Street
Los Angeles, California 90071

Register

Biocom will be holding a roundtable discussion with members of GlaxoSmithKline's Discovery Partnerships in Academia (DPAc) on May 2nd  at 11:30am in the Downtown Los Angeles Area.
 

This roundtable will provide a unique opportunity for you to learn more about DPAc as an organization as well as their interests in collaborations and partnerships. This is also a chance for you to build a relationship with the DPAc team of experts, and for them to understand the research that is currently being conducted in the greater Los Angeles Region. Join us there! 

Attendance is FREE. Space is limited and registration is required. 


About DPAc:
DPAc is a new model for developing truly innovative medicines. It is based on creating a true partnership between world-class academics and the industry-leading scientists of GSK.

The concept is simple but powerful: bring together the insight and creativity of the academic world with the drug discovery expertise of GlaxoSmithKline (GSK) to establish truly integrated partnerships that can translate innovative research into medicines that benefit patients.


The academic researcher supplies depth of scientific knowledge, creativity and a novel concept. The DPAc team provides drug discovery and development experience, applied research expertise and the considerable resources of GlaxoSmithKline (GSK) R&D.

 

Price of Admission

Biocom Member

Today's Price: 0.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Tue May 02 00:00:00 GMT 2017

0.0

Refund after

Refund after

Biocom Non-Member

Today's Price: 0.0

Important Dates

Amount

Registration Before

Registration Before

Registration Before

Refund after Tue May 02 00:00:00 GMT 2017

0.0

Refund after

Refund after

 

Register